Federal contract award
HT001425PE019
IMPLANT DEVICE FOR GLAUCOMA PATIENTS FOR WALTER REED NATIONAL MEDICAL CENTER.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY |
| NAICS | 339115 — Ophthalmic Goods Manufacturing |
| PSC | 6515 — Medical and Surgical Instruments, Equipment, and Supplies |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $211.2K |
| Current contract value | $211.2K |
| Potential contract value / ceiling | $211.2K |
| Start date | Sep 12, 2025 |
| Current end date | Sep 25, 2025 |
| Potential end date | Sep 25, 2025 |
| Latest award activity | Sep 29, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 29, 2025 | P00001 | $0 | THE HYDRUS MICROSTENT IS AN 8MM LONG DEVICE IMPLANTED DURING CATARACT SURGERY TO REDUCE INTRAOCULAR PRESSURE (IOP) IN ADULT PATIENTS WITH MILD TO MODERATE PRIMARY OPEN-ANGLE GLAUCOMA (POAG). |
| Sep 12, 2025 | 0 | $211.2K | IMPLANT DEVICE FOR GLAUCOMA PATIENTS FOR WALTER REED NATIONAL MEDICAL CENTER. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.